Purpose: We at Biomedicon want to successfully market innovative products to cure diseases, to ease suffering, and to enhance the quality of life which in today’s world have deteriorated to a greater extend. We are building a professional team that would be there to make the products known in the market so that people can take more and more advantage of the latest and the advanced technology.
Aspirations: We want to be established for having a positive impact on people's lives with our products, meeting the needs and even surpassing external expectations. We strive to create sustainable earnings growth, ranking in the top quartile of the industry and securing long-term business success. We want to build a reputation for an exciting workplace in which people can achieve their professional ambitions. We strive for a motivating environment where creativity and effectiveness are encouraged and where cutting-edge technologies are applied. In addition, we want to contribute to society through the positive environmental and social benefits of our products.
The aim of the company is to be a nationwide supplier of a wide variety of Urology, Gastroenterology, Interventional Radiology, Interventional Cardiology, diagnostics and Airway Management that measure up to high standards of quality. In its sustained endeavor to constantly upgrade its technology and achieve higher levels of quality, Biomedicon is now seeking to obtain ISO 9000 certification which will be yet another feather in its cap. However, since Biomedicon does not believe in resting on its laurels, it participates in almost every major Trade Fair and Exhibition on all the continents, just to keep abreast with the latest developments and innovations in its field of medical, surgical and scientific equipments and also to gain a deeper consideration of its buyers' needs. Under the dynamic leadership of Mr. J.M. Hegde and the able support of his next generation together with a team of professionals who are progressively expanding and diversifying the company's business, Biomedicon is poised for a quantum leap forward.